Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Share-based Compensation (2017 - 2025)

Historic Share-based Compensation for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $28.1 million.

  • Inspire Medical Systems' Share-based Compensation fell 362.11% to $28.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $130.4 million, marking a year-over-year increase of 1244.21%. This contributed to the annual value of $130.3 million for FY2025, which is 1232.08% up from last year.
  • Per Inspire Medical Systems' latest filing, its Share-based Compensation stood at $28.1 million for Q4 2025, which was down 362.11% from $29.5 million recorded in Q3 2025.
  • Inspire Medical Systems' 5-year Share-based Compensation high stood at $41.7 million for Q2 2025, and its period low was $6.0 million during Q1 2021.
  • For the 5-year period, Inspire Medical Systems' Share-based Compensation averaged around $20.3 million, with its median value being $20.7 million (2023).
  • In the last 5 years, Inspire Medical Systems' Share-based Compensation soared by 11842.92% in 2021 and then plummeted by 362.11% in 2025.
  • Over the past 5 years, Inspire Medical Systems' Share-based Compensation (Quarter) stood at $7.0 million in 2021, then surged by 113.81% to $15.0 million in 2022, then soared by 52.21% to $22.9 million in 2023, then grew by 27.22% to $29.1 million in 2024, then decreased by 3.62% to $28.1 million in 2025.
  • Its last three reported values are $28.1 million in Q4 2025, $29.5 million for Q3 2025, and $41.7 million during Q2 2025.